Baolingbao Biology Co Ltd (002286) — Financial Flexibility Index
Baolingbao Biology Co Ltd (002286) has a Financial Flexibility Index of 0.33x as of September 2025. Free cash flow of CN¥177.26 Million (operating CF CN¥134.96 Million minus capex CN¥42.30 Million) represents 0% of total liabilities (CN¥532.41 Million). Check Baolingbao Biology Co Ltd (002286) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Baolingbao Biology Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Baolingbao Biology Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see 002286 operating cash flow.
Annual Financial Flexibility Index for Baolingbao Biology Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Baolingbao Biology Co Ltd. Explore Baolingbao Biology Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥448.66 Million | CN¥259.36 Million | CN¥547.81 Million | ▲ +18.1% |
| 2024 | 0.69x | CN¥438.65 Million | CN¥248.72 Million | CN¥632.44 Million | ▲ +7.8% |
| 2023 | 0.64x | CN¥434.51 Million | CN¥282.28 Million | CN¥675.41 Million | ▲ +125.8% |
| 2022 | 0.28x | CN¥285.37 Million | CN¥30.82 Million | CN¥1.00 Billion | ▲ +15.8% |
| 2021 | 0.25x | CN¥299.11 Million | CN¥206.27 Million | CN¥1.22 Billion | ▼ -52.9% |
| 2020 | 0.52x | CN¥530.39 Million | CN¥398.46 Million | CN¥1.02 Billion | ▲ +99.1% |
| 2019 | 0.26x | CN¥249.41 Million | CN¥153.95 Million | CN¥951.76 Million | ▼ -11.4% |
| 2018 | 0.30x | CN¥306.76 Million | CN¥133.05 Million | CN¥1.04 Billion | ▲ +177.3% |
| 2017 | 0.11x | CN¥62.05 Million | CN¥-36.91 Million | CN¥581.79 Million | ▼ -78.0% |
| 2016 | 0.49x | CN¥205.51 Million | CN¥108.98 Million | CN¥423.43 Million | ▼ -23.7% |
| 2015 | 0.64x | CN¥276.88 Million | CN¥77.49 Million | CN¥435.44 Million | ▼ -46.3% |
| 2014 | 1.18x | CN¥374.68 Million | CN¥101.77 Million | CN¥316.69 Million | ▲ +22.3% |
| 2013 | 0.97x | CN¥233.06 Million | CN¥85.60 Million | CN¥240.88 Million | ▲ +76.8% |
| 2012 | 0.55x | CN¥161.65 Million | CN¥94.15 Million | CN¥295.31 Million | ▼ -36.6% |
| 2011 | 0.86x | CN¥304.01 Million | CN¥171.70 Million | CN¥352.06 Million | ▲ +51.1% |
| 2010 | 0.57x | CN¥188.27 Million | CN¥27.45 Million | CN¥329.46 Million | ▲ +74.5% |
| 2009 | 0.33x | CN¥138.02 Million | CN¥44.51 Million | CN¥421.50 Million | ▼ -8.1% |
| 2008 | 0.36x | CN¥180.28 Million | CN¥110.77 Million | CN¥505.85 Million | ▼ -53.1% |
| 2007 | 0.76x | CN¥310.67 Million | CN¥78.98 Million | CN¥408.62 Million | ▲ +792.6% |
| 2006 | 0.09x | CN¥33.68 Million | CN¥19.12 Million | CN¥395.40 Million | — |